tirzepatide and cancer risk In a promising new study, the widely used weight-loss drug tirzepatide—known commercially as Mounjaro for diabetes Zepbound for obesity—has shown a surprising secondary benefit: shrinking breast tumors in obese mice tirzepatide cancer risk Is Linked
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31

























